Fluidigm Corp.
http://www.fluidigm.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fluidigm Corp.
Finance Watch: IPOs At A Standstill As US Biotech Stock Valuations Plummet
There have been no biopharma initial public offerings in the US since 12 January while the industry’s valuations have plummeted by double digits since the start of 2022. Nevertheless, venture capital investment continues at a fast pace and there have been some follow-on public offerings.
Execs On The Move, December 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Execs On The Move, September 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medical Device Deals Update, September 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced July-August 2015.
Company Information
- Industry
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice